BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12869643)

  • 1. Molecular modes of action of artesunate in tumor cell lines.
    Efferth T; Sauerbrey A; Olbrich A; Gebhart E; Rauch P; Weber HO; Hengstler JG; Halatsch ME; Volm M; Tew KD; Ross DD; Funk JO
    Mol Pharmacol; 2003 Aug; 64(2):382-94. PubMed ID: 12869643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines.
    Efferth T; Sauerbrey A; Halatsch ME; Ross DD; Gebhart E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):56-67. PubMed ID: 12616342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins.
    Anfosso L; Efferth T; Albini A; Pfeffer U
    Pharmacogenomics J; 2006; 6(4):269-78. PubMed ID: 16432535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antioxidant genes for the activity of artesunate against tumor cells.
    Efferth T; Briehl MM; Tome ME
    Int J Oncol; 2003 Oct; 23(4):1231-5. PubMed ID: 12964009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
    Amundson SA; Myers TG; Scudiero D; Kitada S; Reed JC; Fornace AJ
    Cancer Res; 2000 Nov; 60(21):6101-10. PubMed ID: 11085534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.
    Efferth T; Ramirez T; Gebhart E; Halatsch ME
    Biochem Pharmacol; 2004 May; 67(9):1689-700. PubMed ID: 15081868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
    Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
    Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
    Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.
    Efferth T; Benakis A; Romero MR; Tomicic M; Rauh R; Steinbach D; Häfer R; Stamminger T; Oesch F; Kaina B; Marschall M
    Free Radic Biol Med; 2004 Oct; 37(7):998-1009. PubMed ID: 15336316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of cell cycle by retinoic acid in gastric cancer cells].
    Chen ZM; Wu Q; Chen YQ; Su WJ
    Shi Yan Sheng Wu Xue Bao; 1999 Jun; 32(2):135-40. PubMed ID: 12548778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate.
    Efferth T; Volm M
    In Vivo; 2005; 19(1):225-32. PubMed ID: 15796179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells.
    Youns M; Efferth T; Reichling J; Fellenberg K; Bauer A; Hoheisel JD
    Biochem Pharmacol; 2009 Aug; 78(3):273-83. PubMed ID: 19393226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
    Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
    Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray-based prediction of cytotoxicity of tumor cells to cantharidin.
    Efferth T
    Oncol Rep; 2005 Mar; 13(3):459-63. PubMed ID: 15706417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro.
    van Erk MJ; Roepman P; van der Lende TR; Stierum RH; Aarts JM; van Bladeren PJ; van Ommen B
    Eur J Nutr; 2005 Mar; 44(3):143-56. PubMed ID: 15309432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.